People walk with belongings after crossing the Oskil River bridge while fleeing the frontline town of Kupiansk, Kharkiv region, on September 24, 2022, amid Russia's military invasion on Ukraine. - In ...
The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...
Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...
Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat a ...
NEW YORK (PIX11) – A nose spray has been approved by the U.S. Food and Drug Administration to help treat depression, Johnson & Johnson announced on Tuesday. Spravato is a first-of-its-kind ...
The conversation, part of Frontline’s 40th-anniversary celebrations, reflected the magazine’s commitment to deep, nuanced journalism. Roy noted that the special anniversary issue features 10 essays by ...
The events of Jan. 6 were seen at the time as “universally terrible,” former Fox News anchor Megyn Kelly, host of The Megyn Kelly Show, tells FRONTLINE in the new documentary Trump’s Comeback.
Most products come in a hand-operated pump bottle or squeeze bottle. Knowing how to use a nasal spray is important, as doing it incorrectly could affect the dose you receive. There are many OTC and ...
Explore FRONTLINE’s documentaries and reporting on the roots, evolution and impact of the war and the overarching Israeli-Palestinian conflict, its sprawling ramifications, and how the most ...
About a third of the 1.4 million people seen as prime targets for deportation live in Florida and Texas - both states which have supported crackdowns Migrants living under 'final orders of removal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results